NFE2L2 and lung carcinoma: A series of novel indolyl-chalcone derivatives were synthesized and evaluated for anticancer activity by demonstrating the effect of in vitro and in vivo cell apoptosis of a human lung cancer cell line A549 by activating the Nrf2/HO-1 pathway without any change in normal angiogenesis 202.